Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

Combining pioneering iPSC technology and patented live cell bioimaging, LumiSTAR is opening up exciting new possibilities in the treatment of various diseases and the development of innovative new dru ...

3 Retinal pigment epithelial cells (RPE cells ... as typified by the differentiation of iPS cells. This is because of two technical barriers to cell culture - the fact that minute differences in ...

With a laminar cell organization resembling embryonic development, the retinal organoids, derived from iPSCs, replicate the intricate structure of the human retina. They house the retina’s light ...

iPS cells are being used to treat eye diseases to address donor shortages. We explore advancements made in Japan, such as the transplantation of iPS cell-derived corneal cells and retinal sheets.

Clinical studies and trials have shown a certain degree of safety in using this approach to treat retinal and corneal ... Efforts to use iPS cells to develop powerful new treatments for a range ...

A combination of next generation sequencing, single cell omics, patient derived iPSC and retinal organoid, mice and non human primate models, and machine learning and deep learning technologies are ...

This eventually leads to the accumulation of toxic forms of vitamin A, causing retinal cell death. As these cells die, people gradually lose the ability to read, drive, and recognize faces. “Because ...

In hopes of identifying this subset of we have undertaken an extensive transcriptome analysis of paired trisomic/disomic induced pluripotent stem cells (iPSCs) and cortical neuronal cultures derived ...